These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3503432)

  • 21. [Alzheimer's disease and the association of genetic polymorphism of apolipoprotein E and liquor beta protein in Finns].
    Lehtimäki T; Pirttilä T; Frey H; Nikkari T
    Duodecim; 1995; 111(5):401-7. PubMed ID: 8674441
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on human apolipoprotein E genetic isoforms and their phenotypes among the Chinese population.
    Wang KQ; He JL; Xie YH
    Proc Chin Acad Med Sci Peking Union Med Coll; 1987; 2(3):133-9. PubMed ID: 3444834
    [No Abstract]   [Full Text] [Related]  

  • 23. [Problems of familial disposition to atherosclerosis].
    Válek J; Grafnetter D; Honzák R; Kohout M; Slabochová Z
    Vnitr Lek; 1976 Mar; 22(3):232-8. PubMed ID: 1266083
    [No Abstract]   [Full Text] [Related]  

  • 24. The key role of apolipoprotein E in atherosclerosis.
    Greenow K; Pearce NJ; Ramji DP
    J Mol Med (Berl); 2005 May; 83(5):329-42. PubMed ID: 15827760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phenotype of apolipoprotein E, hyperlipidemia and atherosclerosis].
    Davignon J; Roederer G
    Union Med Can; 1988 Feb; 117(1):56-61. PubMed ID: 3376345
    [No Abstract]   [Full Text] [Related]  

  • 26. Apolipoprotein E phenotype and renal disease.
    Oda H; Yorioka N; Ueda C; Nishida Y; Yamakido M
    Contrib Nephrol; 1997; 120():22-9. PubMed ID: 9257044
    [No Abstract]   [Full Text] [Related]  

  • 27. Apolipoprotein E and atherosclerosis in Greenland Inuit.
    Boudreau DA; Scheer WD; Malcom GT; Mulvad G; Pedersen HS; Jul E
    Atherosclerosis; 1999 Jul; 145(1):207-19. PubMed ID: 10428312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary fat intake in relation to apo E isoforms and body fat distribution in obese women.
    Muls E; Vansant G; Beirinckx AM; Jans I
    Acta Cardiol; 1993; 48(5):473-5. PubMed ID: 8284984
    [No Abstract]   [Full Text] [Related]  

  • 29. The significance of apolipoprotein variants.
    Menzel HJ; Utermann G
    Prog Clin Biol Res; 1988; 255():63-72. PubMed ID: 2963348
    [No Abstract]   [Full Text] [Related]  

  • 30. [Polymorphism of apolipoprotein E in non-insulin dependent diabetes mellitus].
    del Pozo C; Serrat J; Homs R; Sorribas A; Gómez JA
    Med Clin (Barc); 1988 Sep; 91(8):289-92. PubMed ID: 3210824
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of a gender difference in the apolipoprotein E gene DNA polymorphism on serum lipid levels in a Serbian healthy population.
    Stanković S; Glisic S; Alavanatić D
    Clin Chem Lab Med; 2000 Jun; 38(6):539-44. PubMed ID: 10987203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epsilon 4: a genetic factor susceptible to hypercholesterolemia].
    Xie YH
    Zhonghua Yi Xue Za Zhi; 1989 Oct; 69(10):585-7. PubMed ID: 2620269
    [No Abstract]   [Full Text] [Related]  

  • 33. The apo E-system: genetic control of plasma lipoprotein concentration.
    Utermann G
    Adv Exp Med Biol; 1986; 201():261-72. PubMed ID: 3541519
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of monoclonal antibodies to detect genetic polymorphism: application to apolipoprotein B.
    Schumaker VN; Balla MA; Robinson M; Spence MA; Sparkes RS; Elovson J; Curtiss LK
    Prog Clin Biol Res; 1985; 177():375-92. PubMed ID: 2409560
    [No Abstract]   [Full Text] [Related]  

  • 35. Apolipoprotein E and atherosclerosis: insight from animal and human studies.
    Davignon J; Cohn JS; Mabile L; Bernier L
    Clin Chim Acta; 1999 Aug; 286(1-2):115-43. PubMed ID: 10511288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Genetic mutants of plasma apolipoprotein E--apo E-5 and apo E-Suita--associated with hyperlipidemia and atherosclerosis].
    Yamamura T; Yokoyama S; Yamamoto A; Sumiyoshi T; Hiramori K; Nishioeda Y; Tsushima M; Nambu S; Ikeda M
    Nihon Naika Gakkai Zasshi; 1985 Jan; 74(1):62-9. PubMed ID: 3998580
    [No Abstract]   [Full Text] [Related]  

  • 37. Apolipoprotein E4: another risk factor for cholesterol gallstone formation?
    Van Erpecum KJ; Carey MC
    Gastroenterology; 1996 Dec; 111(6):1764-7. PubMed ID: 8942760
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetic polymorphisms and atherosclerosis.
    Galton DJ
    Monogr Atheroscler; 1986; 14():113-8. PubMed ID: 3090427
    [No Abstract]   [Full Text] [Related]  

  • 39. Apolipoprotein E mutants, hyperlipidemia and arteriosclerosis.
    Utermann G
    Adv Exp Med Biol; 1985; 183():173-88. PubMed ID: 4036699
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter by Singh et al regarding article, "Apolipoprotein E polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the GOLDN study".
    Singh P; Di Napoli M; Singh M
    Circ Cardiovasc Genet; 2011 Feb; 4(1):e5; author reply e6. PubMed ID: 21325156
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.